Altria Science






Our Science Supports:

Tobacco Harm Reduction
Evidence-Based Decision Making
Tobacco Product Innovation

We invest in the core science needed to demonstrate that new products are in fact less harmful than cigarettes. We have recruited scientists from around the world, from many different disciplines, who share the common goal of tobacco harm reduction.

We have a team of more than 300 scientists, physicians, product developers, engineers, regulatory experts and others who are dedicated to developing innovative products, pursuing their regulatory authorization and constructively engaging with the FDA on policy. Much of this work occurs at our Center for Research and Technology (CRT) in Richmond, Virginia.

COVID-19 image

COVID-19 & Tobacco Use

Studies are emerging on unanswered COVID-19 questions, including data on the potential relationships between smoking, vaping, coronavirus infection and severe complications.
Scientists in a lab

Our Scientists

We have recruited scientists from around the world, from many different disciplines, who share the common goal of tobacco harm reduction.

Tobacco Harm Reduction

We support several approaches to reducing the harm caused by tobacco products.
File folders stacked on a desk

FDA Submissions

We share information with the FDA through written submissions, presentations and other communications.